myfortic 180 mg gastro - resistant tablets
novartis pharma gmbh - Микофеноловая киселина - 180 mg gastro - resistant tablets
myfortic 360 mg gastro - resistant tablets
novartis pharma gmbh - Микофеноловая киселина - 360 mg gastro - resistant tablets
teysuno
nordic group b.v. - тегафур, gimeracil, oteracil - Стомашни неоплазми - Антинеопластични средства - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Хеморагична Треска Ебола - Ваксини - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
xaloptic 50 micrograms/ml eye drops, solution
50 micrograms/ml eye drops, solution
xaloptic combi 0,05 mg/5 mg/ml eye drops
0,05 mg/5 mg/ml eye drops
imvanex
bavarian nordic a/s - модифицирана ваксиния Анкара - баварски северни (mva-bn) вируси - smallpox vaccine; monkeypox virus - Други вирусни ваксини, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 и 5. Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.
anagrelid nordic 0,5 mg tablets
0,5 mg tablets
anagrelid nordic 0,75 mg tablets
0,75 mg tablets
anagrelid nordic 1 mg tablets
1 mg tablets